Testing effectiveness (Phase 2)Study completedNCT00535028
What this trial is testing
A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
Who this might be right for
Allergic Asthma
Aerovance, Inc. 24